BCL2 and cancer: STAT3 exacerbates breast cancer via IL6/JAK/STAT3, EGFR/VEGFR signaling, et al. Consequently, the cancer-aggravating downstream targets, e.g. Bcl2, CCND1, MMPs, et al., are robustly up-regulated which results in cancer progression 9.